← Back to Clinical Trials
Recruiting NCT07481916

NCT07481916 Inspiratory Muscle Warm-Up in Combat Athletes

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07481916
Status Recruiting
Phase
Sponsor Ondokuz Mayıs University
Condition Sports Performance
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2026-01-01
Primary Completion 2026-05-15

Eligibility & Interventions

Sex All sexes
Min Age 15 Years
Max Age 22 Years
Study Type INTERVENTIONAL
Interventions
POWERbreathePOWERbreathe

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2026-01-01 with a primary completion date of 2026-05-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The aim of this study is to investigate the effects of inspiratory muscle warm-up (IMW) on technical performance and physiological responses in combat athletes. A total of 20 volunteer athletes (10 males, 10 females), aged 15-22 years, registered with the Turkish Kickboxing and Muay Thai Federation, with at least two years of licensed sports experience and medal achievements at the national or international level, will be included in the study. The study will be conducted using a placebo-controlled, randomized, double-blind, crossover experimental design, in which participants will complete the control (general warm-up), placebo (15% MIP), and IMW (40% MIP) conditions in a random order. In each session, before and after the warm-up, pulmonary function tests (FVC, FEV1, FEV1/FVC, PEF), respiratory muscle strength (MIP, MEP), heart rate, perceived exertion, and dyspnea levels will be assessed. In addition, athletes will perform the Kickboxing Fitness Test (KFT), and the same measurements will be repeated during the rest intervals of the test and immediately after its completion. The IMW protocol will be performed using a POWERbreathe device at 40% of MIP, consisting of 2 sets of 30 breaths. Furthermore, maximal oxygen uptake (VO₂max) tests will be conducted to evaluate the athletes' general physiological capacity. This study is expected to provide original data for the field of sports sciences by demonstrating the potential contributions of inspiratory muscle warm-up to the improvement of technical skills and physiological capacity in combat athletes, and to generate practical scientific recommendations for coaches and athletes.

Eligibility Criteria

Inclusion Criteria: * Male and female combat athletes aged 15 to 22 years * Registered with the Turkish Kickboxing and Muay Thai Federation * Regularly engaged in training * At least 2 years of licensed sports experience * Having won medals at the national or international level Exclusion Criteria: * Presence of respiratory disease * Presence of cardiopulmonary disease

Contact & Investigator

Central Contact

Nazlıcan Toprak, MSc

✉ nazli.tprk55@gmail.com

📞 +90 5372721255

Principal Investigator

Özgür Bostancı

STUDY DIRECTOR

University of ondokuz mayıs

Frequently Asked Questions

Who can join the NCT07481916 clinical trial?

This trial is open to participants of all sexes, aged 15 Years or older, up to 22 Years, studying Sports Performance. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07481916 currently recruiting?

Yes, NCT07481916 is actively recruiting participants. Contact the research team at nazli.tprk55@gmail.com for enrollment information.

Where is the NCT07481916 trial being conducted?

This trial is being conducted at Samsun, Turkey (Türkiye).

Who is sponsoring the NCT07481916 clinical trial?

NCT07481916 is sponsored by Ondokuz Mayıs University. The principal investigator is Özgür Bostancı at University of ondokuz mayıs. The trial plans to enroll 20 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology